Literature DB >> 20223232

Etazolate improves performance in a foraging and homing task in aged rats.

Jason Drott1, L Desire, D Drouin, M Pando, Forrest Haun.   

Abstract

Etazolate is a phosphodiesterase 4 (PDE4) inhibitor and GABAA receptor modulator that also stimulates alpha-secretase activity and neurotrophic soluble amyloid precursor protein (sAPPalpha) production, currently developed as a possible Alzheimer's disease therapeutic. In this study two doses of etazolate were tested for cognitive effects in normally aged rats, using a complex spatial learning and memory task that emphasized two naturally occurring behaviors in rodents, foraging for food and returning large pieces of found food to a safe home location. Both etazolate doses completely prevented both (1) a foraging deficit that developed in untreated aged rats over the course of the test, as well as (2) a trial-specific deficit in memory for previously visited food locations that also developed over the course of the test in untreated aged rats. Both doses also significantly reduced a separate memory deficit for changing locations of the animals' home box, plus completely prevented a significant tendency for untreated aged animals to attempt entry into similar-appearing but incorrect home boxes. The combined behavioral data demonstrate positive effects of etazolate on separate age-related cognitive deficits, using a complex task based on naturally occurring rodent behaviors. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223232     DOI: 10.1016/j.ejphar.2010.02.036

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Authors:  Ankur Jindal; Radhakrishnan Mahesh; Shvetank Bhatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

Review 2.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

3.  Foraging activity is reduced in a mouse model of depression.

Authors:  C R Yang; Z G Zhang; Y Y Bai; H Fiona Zhou; L Zhou; C S Ruan; F Li; C Q Li; H Y Zheng; L J Shen; X F Zhou
Journal:  Neurotox Res       Date:  2013-07-20       Impact factor: 3.911

4.  Rolipram treatment during consolidation ameliorates long-term object location memory in aged male mice.

Authors:  Mathieu E Wimmer; Jennifer M Blackwell; Ted Abel
Journal:  Neurobiol Learn Mem       Date:  2020-01-19       Impact factor: 2.877

5.  Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.

Authors:  Chuang Wang; Jianrui Zhang; Yang Lu; Peipei Lin; Tonghe Pan; Xin Zhao; Aiming Liu; Qinwen Wang; Wenhua Zhou; Han-Ting Zhang
Journal:  Metab Brain Dis       Date:  2014-04-05       Impact factor: 3.584

Review 6.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.

Authors:  Karan Govindpani; Beatriz Calvo-Flores Guzmán; Chitra Vinnakota; Henry J Waldvogel; Richard L Faull; Andrea Kwakowsky
Journal:  Int J Mol Sci       Date:  2017-08-21       Impact factor: 5.923

Review 7.  Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα.

Authors:  Bruce G Mockett; Max Richter; Wickliffe C Abraham; Ulrike C Müller
Journal:  Front Mol Neurosci       Date:  2017-02-07       Impact factor: 5.639

Review 8.  GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment.

Authors:  Yilan Xu; Manna Zhao; Yuying Han; Heng Zhang
Journal:  Front Neurosci       Date:  2020-06-30       Impact factor: 4.677

Review 9.  Implications of GABAergic Neurotransmission in Alzheimer's Disease.

Authors:  Yanfang Li; Hao Sun; Zhicai Chen; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  Front Aging Neurosci       Date:  2016-02-23       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.